Review on the Synthesis and Therapeutic Potential of Pyrido[2,3-

N-heterocycles biological activity pyridopyrimidines synthesis

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
14 Mar 2022
Historique:
received: 26 01 2022
revised: 03 03 2022
accepted: 10 03 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 27 3 2022
Statut: epublish

Résumé

The objective of this review is to list the structures composed of a pyridopyrimidine moiety which have shown a therapeutic interest or have already been approved for use as therapeutics. We consider all the synthetic protocols to prepare these pyridopyrimidine derivatives. The review is organized into four sections, successively pyrido[2,3-

Identifiants

pubmed: 35337149
pii: ph15030352
doi: 10.3390/ph15030352
pmc: PMC8949896
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Mol Cancer Ther. 2019 Oct;18(10):1696-1707
pubmed: 31575759
J Biol Chem. 2020 Mar 6;295(10):3055-3063
pubmed: 32001619
Endocr Rev. 2001 Apr;22(2):153-83
pubmed: 11294822
Clin Cancer Res. 2021 Mar 1;27(5):1463-1475
pubmed: 33355298
Biochem Pharmacol. 2006 Mar 30;71(7):941-8
pubmed: 16359642
Oncogene. 2004 Apr 12;23(16):2838-49
pubmed: 15077147
PLoS One. 2012;7(8):e39922
pubmed: 22876277
Biochem J. 2005 Dec 1;392(Pt 2):249-61
pubmed: 16293107
Expert Opin Ther Pat. 2020 Feb;30(2):103-120
pubmed: 31913776
J Med Chem. 1999 Sep 9;42(18):3421-4
pubmed: 10479275
Biochem Biophys Res Commun. 2018 May 15;499(3):425-432
pubmed: 29571732
J Med Chem. 1996 Mar 29;39(7):1438-46
pubmed: 8691474
J Med Chem. 1993 Oct 29;36(22):3437-43
pubmed: 8230134
Molecules. 2019 Mar 22;24(6):
pubmed: 30909399
Appl Microbiol Biotechnol. 2011 Jan;89(1):17-25
pubmed: 20882276
Transcription. 2019 Apr;10(2):118-136
pubmed: 30409083
Mol Cancer Ther. 2015 Feb;14(2):317-25
pubmed: 25376610
J Med Chem. 2018 Sep 27;61(18):8226-8240
pubmed: 30199249
Int J Mol Sci. 2016 May 14;17(5):
pubmed: 27187381
Eur J Pain. 2011 Nov;15(10):1040-8
pubmed: 21576029
Biochim Biophys Acta. 2007 Aug;1773(8):1263-84
pubmed: 17126425
Invest New Drugs. 2017 Feb;35(1):47-58
pubmed: 27650277
PLoS One. 2010 Oct 01;5(10):
pubmed: 20957036
ACS Chem Biol. 2016 Dec 16;11(12):3400-3411
pubmed: 27768280
Front Cell Dev Biol. 2016 Aug 30;4:91
pubmed: 27626031
J Biol Chem. 2008 Nov 14;283(46):31401-7
pubmed: 18796434
J Med Chem. 1998 Aug 13;41(17):3276-92
pubmed: 9703473
J Med Chem. 2020 Sep 24;63(18):10188-10203
pubmed: 32407112
N Engl J Med. 2017 Nov 9;377(19):1813-1823
pubmed: 28891408
Recent Results Cancer Res. 2018;211:91-100
pubmed: 30069762
Bioorg Med Chem Lett. 2013 Mar 1;23(5):1212-6
pubmed: 23375793
J Med Chem. 2008 Oct 9;51(19):6195-200
pubmed: 18771252
Front Mol Biosci. 2021 Jan 12;7:615614
pubmed: 33511159
Eur J Med Chem. 2015 May 5;95:76-95
pubmed: 25794791
Curr Top Med Chem. 2019;19(23):2081-2097
pubmed: 31486755
Eur J Med Chem. 2019 Aug 1;175:247-268
pubmed: 31121430
Sci Signal. 2018 Jan 02;11(511):
pubmed: 29295955
Rheumatology (Oxford). 2021 Mar 2;60(3):1364-1375
pubmed: 32949140
Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10631-6
pubmed: 17548827
Cancer Discov. 2019 Oct;9(10):1388-1405
pubmed: 31315834
J Med Chem. 1996 Mar 15;39(6):1271-80
pubmed: 8632434
Crit Care Med. 2015 Sep;43(9):1859-69
pubmed: 26102252
Bioorg Med Chem Lett. 2011 Mar 1;21(5):1315-9
pubmed: 21310613
Nat Med. 2014 Mar;20(3):255-64
pubmed: 24531378
Science. 2011 Jan 21;331(6015):334-7
pubmed: 21252347
J Org Chem. 2005 Feb 18;70(4):1364-8
pubmed: 15704971
N Engl J Med. 2016 Nov 17;375(20):1925-1936
pubmed: 27959613
Annu Rev Biochem. 1983;52:537-79
pubmed: 6137188
N Engl J Med. 2015 Jul 16;373(3):209-19
pubmed: 26030518
FASEB J. 1990 May;4(8):2441-52
pubmed: 2185970
Cancer Treat Rev. 2020 Sep;89:102070
pubmed: 32711246
Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):
pubmed: 28620096
Invest New Drugs. 2018 Feb;36(1):36-44
pubmed: 28417284
Biomedicines. 2020 Jul 03;8(7):
pubmed: 32635204
Chem Biol Drug Des. 2021 Mar;97(3):633-648
pubmed: 32946161
Cell Mol Life Sci. 2013 Mar;70(5):863-91
pubmed: 22869039
J Med Chem. 1980 Mar;23(3):327-9
pubmed: 6928967
Development. 2013 Aug;140(15):3079-93
pubmed: 23861057
Cytokine. 2015 Nov;76(1):25-37
pubmed: 26185894

Auteurs

Joana F Campos (JF)

Institut de Chimie Organique et Analytique (ICOA), Université d'Orléans CNRS, ICOA UMR 7311, BP 6759, Rue de Chartres, CEDEX 2, 45067 Orléans, France.

Thierry Besson (T)

Université de Rouen-Normandie (UNIROUEN), INSA Rouen, CNRS, COBRA UMR 6014, 76000 Rouen, France.

Sabine Berteina-Raboin (S)

Institut de Chimie Organique et Analytique (ICOA), Université d'Orléans CNRS, ICOA UMR 7311, BP 6759, Rue de Chartres, CEDEX 2, 45067 Orléans, France.

Classifications MeSH